We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Case Report: Neoadjuvant PD-1 Blockade Plus Concurrent Chemoradiotherapy in Unresectable Locally Advanced Gastric Cancer Patients.
- Authors
Wei, Jia; Lu, Xiaofeng; Liu, Qin; Li, Lin; Liu, Song; Liu, Fangcen; Fu, Yao; Fan, Xiangshan; Yang, Yang; Qi, Chuang; Yu, Yangyang; Guan, Wenxian; Liu, Baorui
- Abstract
Programmed death 1(PD-1) blockade has shown promising efficacy in advanced gastric cancer. Here, we performed a retrospective analysis of three patients with locally advanced gastric cancer who received adjuvant PD-1 plus chemoradiotherapy as neoadjuvant treatment. Neoadjuvant sintilimab plus concurrent chemoradiotherapy had an acceptable side-effect profile. All three patients underwent surgical gastrectomy after a median of 3.9 months. A major pathological response occurred in two resected tumors and a pathologic complete response was observed in one patient. Our results suggest that PD-1 blockade combined with chemoradiotherapy is a promising strategy as a neoadjuvant therapy in patients with unresectable locally advanced gastric cancer.
- Subjects
STOMACH cancer; CHEMORADIOTHERAPY; PROGRAMMED cell death 1 receptors; CANCER patients
- Publication
Frontiers in Oncology, 2021, Vol 11, pN.PAG
- ISSN
2234-943X
- Publication type
Article
- DOI
10.3389/fonc.2020.554040